ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

Japanese drugmaker plans companion diagnostic for Opdivo

OSAKA -- Ono Pharmaceutical will develop a diagnostic test to identify patients who would benefit from its Opdivo cancer drug, allowing for more efficient treatment and lower medical costs.

     The Japanese drugmaker assembled a team of six companion-diagnostics researchers to identify relevant cancer biomarkers. They already have found one marker that determines how well a patient could respond to the drug.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more